MATERIAL SAFETY DATA SHEET
Emamectin benzoate 5% WDG
1.
IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
PRODUCT NAME: Emamectin benzoate 5% WDG
CHEMICAL NAME: Avermectin BI, 4"-deoxy-4"-(methylamino)-,(4"R)-, benzoate (salt)
CHEMICAL FORMULA: C49H77NO13
MOLECULAR WEIGHT: 888.13
USAGE: Insecticide
MANUFACTURER & ADDRESS:
EASYTRANS LOGISTICS COMPANY LIMITED
2.
COMPOSITION/INFORMATION ON INGREDIENT
Components
Emamectin benzoate
Inert Ingredients
3.
CAS Number
155569-91-8
--
%
5.0
95.0
HAZARD IDENTIFICATION
Risk Phrases:
R 22 Harmful if swallowed
R 36 Irritating to eyes
Hazardous Decomposition Products: Can decompose at high temperatures forming toxic gases.
4.
FIRST AID MEASURES
Ingestion: If swallowed: a poison control center or doctor immediately for treatment advice. Have the
person sip a glass of water if able to swallow. Do not induce vomiting unless told to do so after calling by a
poison control center or doctor. Do not give anything by mouth to an unconscious person.
Eye Contact: If in eyes: Hold eye open and rinse slowly and gently with water for 15-20 minutes. Remove
contact lenses, if present, after 5 minutes, then continue rinsing eye.
Skin Contact: If on skin or clothing: Take offcontaminated clothing. Rinse skin immediately with plenty
of water for 15- 20 minutes.
Inhalation: If inhaled: Move person to fresh air. If person is not breathing, call an ambulance, then give
artificial respiration, preferably mouth-to-mouth if possible.
Notes to Physician: There is no specific antidote if this product is ingested. Recommendations for Medical
Treatment for Emamectin Benzoate Acute Toxicity: Early signs of intoxication include mydriasis (dilated
pupils), ataxia (unsteadiness), and muscle tremors. Toxicity following accidental ingestion of the
concentrate can be minimized by inducing vomiting within 1/2 hour exposure. If toxicity from exposure
1/4
has progressed to cause severe vomiting, the extent of resultant fluid and electrolyte imbalance should be
gauged. Appropriate supportive parenteral fluid replacement therapy should be given, along with other
required supportive measures (such as maintenance of blood pressure levels) as indicated by clinical signs,
symptoms, and measurements. In severe cases, observations should continue for at least several days until
clinical condition is stable and normal. Since emamectin benzoate is believed to enhance GABA activity in
animals, it is wise to avoid drugs that enhance GABA activity (barbiturates, benzodiazepines, valproic acid)
in patients with a potentially toxic exposure.
Medical Condition Likely to be Aggravated by Exposure: Individuals with pre-existing eye lesions or
nervous system dysfunctions should avoid contact with this material.
5.
FIRE FIGHTING MEASURES
Unusual Fire, Explosion and Reactivity Hazards During a fire, irritating and possibly toxic gases may
be generated by thermal decomposition or combustion.
In Case of Fire: Use dry chemical, foam or C02 extinguishing media. Wear full protective clothing and
self-contained breathing apparatus. Evacuate nonessential personnel from the area to prevent human
exposure to fire, smoke, fumes or products of combustion. Prevent use of contaminated buildings, area,
and equipment until decontaminated. Water runoff can cause environmental damage. If water is used to
fight fire, dike and collect runoff.
6.
ACCIDENTAL RELEASE MEASURES
In Case of Spill or Leak Control the spill at its source. Contain the spill to prevent it from spreading,
contaminating soil, or entering sewage and drainage systems or any body of water. Clean up spills
immediately, observing precautions outlined in Section 8. If a solid, sweep up material and place in a
compatible disposal container. Pick up wash liquid with additional absorbent and place into compatible
disposal container. Once all material is cleaned up and placed in a disposal container, seal container and
arrange for disposition.
7.
HANDLING AND STORAGE
Store the material in a well-ventilated, secure area out of reach of children and domestic animals. Do not
store food, beverages or tobacco products in the storage area. Prevent eating, drinking, tobacco use, and
cosmetic application in areas where there is a potential for exposure to the material. Wash thoroughly with
soap and water after handling.
8.
EXPOSURE CONTROLS/PERSONAL PROTECTION
The following recommendations for exposure controls/personal protection are intended for the
manufacture, formulation, packaging and use of this product. For commercial applications and/or on-farm
applications consult the product label.
2/4
Ingestion: Prevent eating, drinking, tobacco usage and cosmetic application in areas where there is a
potential for exposure to the material. Wash thoroughly with soap and water after handling.
Eye Contact: Where eye contact is likely, use chemical splash goggles. Facilities storing or utilizing this
material should be equipped with an eyewash facility and a safety shower.
Skin Contact: Where contact is likely, wear chemical-resistant (such as nitrile or butyl) gloves, coveralls,
socks and chemical-resistant footwear. For overhead exposure, wear chemical-resistant headgear.
Inhalation: A combination particulate/ organic vapor respirator may be necessary until effective
engineering controls are installed to comply with occupational exposure limits. Use a NIOSH approved
respirator with an organic vapor (OV) cartridge or canister with an HE prefilter. Use a self-contained
breathing apparatus in cases of emergency spills, when exposure levels are unknown, or under any
circumstances where air-purifying respirators may not provide adequate protection.
9.
PHYSICAL AND CHEMICAL PROPERTIES
Appearance: Off-white granule
Melting Point: Not Available
Boiling Point: Not Applicable
PH: 6.0-8.0
Suspensibility: ≥80.0
10.
STABILITY AND REACTIVITY
Stability: Stable under normal use and storage conditions.
Hazardous Polymerization: Will not occur.
Conditions to Avoid: Heat and light.
Materials to Avoid: None known.
Hazardous Decomposition Products: Can decompose at high temperatures forming toxic gases.
11.
TOXICOLOGICAL INFORMATION
Acute Toxicity - Oral LD50: 1510 mg/kg
Acute Toxicity - Dermal LD50: >200 mg/kg
Acute Toxicity -Inhalation LC50 (rat) (4hr) > 6.2 mg/l
Eye Irritation Mild eye irritant.
Skin Irritation Mild skin irritant.
Sensitisation: Shouldn’t cause sensitisation by skin contact.
12.
ECOLOGICAL INFORMATION
Birds: Acute oral LD50 for mallard ducks 46, bobwhite quail 264 mg/kg. Dietary LC50 (8 d) for mallard
ducks 570, bobwhite quail 1318 ppm.
3/4
Fish: LC50 (96 h) for rainbow trout 174, sheepshead minnow 1430 µg/l.
Daphnia: LC50 0.99 µg/l.
Bees: LD50 (24h) oral 0.0036 µg/bee
13.
DISPOSAL CONSIDERATIONS
Disposal: Do not reuse product containers. Dispose of product containers, waste containers, and residues
according to local, state, and federal health and environmental regulations.
Characteristic Waste: Not Applicable
Listed Waste: Not Applicable
14.
TRANSPORT INFORMATION
UN Number: 3077
Hazard class: 9
Packing group: Ⅲ
15.
REGULATORY INFORMATION
No data
16.
OTHER INFORMATION
STATEMENT NOTICE
The information and recommendations contained herein is believed to be reliable and are presented in
good faith by the supplier. The information is supplied upon the condition that users and handlers of the
product will make their own determination as to its suitability for their purpose prior to use. In no event
will the supplier be responsible for damages of any nature concerning the handling and use of this
product. Handlers and users of the product assume all risks and liabilities arising from its handling, use
or application.
4/4